Pembrolizumab May Be Preferable to Chemo in Certain Patients

NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction

Read more